Circulating thrombopoietin in clonal versus reactive thrombocytosis.

The aim of this study is to assess circulating thrombopoietin concentrations in patients with both clonal and reactive thrombocytosis (RT), which are two distinct categories of extreme platelet production circumstances. Investigation of the thrombopoietin levels in clonal versus reactive thrombocytosis may help us to understand the interactions of this key regulatory cytokine and the conditions in which abnormally increased platelet formation exist.
Thrombopoietin levels were measured in patients with platelet counts greater than 500 x1 0(3) microl(-1). The study population consisted of 21 patients with RT (13 with iron deficiency anemia, and 8 with rheumatoid arthritis), 24 patients with clonal thrombocytosis (six with essential thrombocytosis, three with myelofibrosis, eight with chronic myelogenous leukemia, and seven with polycythemia vera (PV)) and 16 healthy subjects were used as controls.
The median plasma thrombopoietin concentration was 100.5 pg ml(-1) in patients with RT, 467 pg ml(-1) in patients with clonal thrombocytosis and 62.65 pg ml(-1) in the control group. The thrombopoietin concentration was found to be higher in the patients with primary thrombocytosis when compared to the control group (p=0.001), as well as in patients with RT (p=0.002). However, there was no statistically significant difference between the patients with RT and the control group (p=0.14). There was no correlation between thrombopoietin levels and the platelet counts in patients with clonal thrombocytosis, including essential thrombocythemia (ET). CONCLUSIION: Increased levels of thrombopoietin were found in patients with clonal thrombocytosis versus patients with RT and control subjects as well. Defective clearance of thrombopoietin by megakaryocytes and platelets due to a reduced number of thrombopoietin receptors may be the causative mechanism behind this. These results indicate that plasma thrombopoietin levels may be helpful in distinguishing between clonal and reactive thrombocytosis.
AuthorsSema Karakuş, Osman I Ozcebe, Ibrahim C Haznedaroğlu, Hakan Göker, Düzgün Ozatli, Ali Koşar, Yahya BüyükaşIk, Derun Ertuğrul, Nilgün SayInalp, Serafettin KirazlI, Semra V Dündar
JournalHematology (Amsterdam, Netherlands) (Hematology) Vol. 7 Issue 1 Pg. 9-12 (Feb 2002) ISSN: 1024-5332 [Print] England
PMID12171772 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Biomarkers
  • Thrombopoietin
  • Adult
  • Aged
  • Biomarkers (blood)
  • Case-Control Studies
  • Clone Cells (pathology)
  • Diagnosis, Differential
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Middle Aged
  • Myeloproliferative Disorders (blood, diagnosis)
  • Thrombocytosis (blood, diagnosis, etiology)
  • Thrombopoietin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: